Our study provides compelling evidence of the amelioration of steatosis with hEC-SOD administration, demonstrating histological improvements that extend to steatosis and fibrosis through activating AMPK and its associated downstream targets involved in lipid metabolism (Figure 1). This evidence concerns the gene SOD1 and steatosis.